Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1135 ops.)
Latest filing published 16 Oct 2026 for UNITED THERAPEUTICS Corp, €998k. Read the official filing
Filing timeline
BuySaleMartine A. Rothblatt
First 200 filings with a declared amount
Insider track record
Disclosed buys
0
Disclosed sells
1,135
Signal history
Martine A. Rothblatt: trading record in brief
This profile gathers the share dealings of Martine A. Rothblatt across 2 companies, led by UNITED THERAPEUTICS Corp and BETA Technologies, Inc. The record holds 1,450 filings, for trades running from 31 December 2015 to 15 October 2026.
The open-market record consists of 1,135 sales worth €419.2M, with no purchase. The totals do not cover 34 filings with an undisclosed amount. Outside the open market, there are 2 share grants and 307 option exercises. In 2026 alone, the filings show no purchases and 1,101 sales.
Most recently, on 16 October 2026, the filings show an option exercise worth €998k in UNITED THERAPEUTICS Corp. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Martine A. Rothblatt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1,450 total
9,500 shares@ US$117.760.0048% mcap0.1% of flowCommon StockSEC:0001106578-26-000165:0
1,163 shares@ US$541.58590.0027% mcap0.1% of flowCommon StockSEC:0001106578-26-000165:2
456 shares@ US$542.67930.0011% mcap0.0% of flowCommon StockSEC:0001106578-26-000165:3
371 shares@ US$543.39290.0009% mcap0.0% of flowCommon StockSEC:0001106578-26-000165:4
269 shares@ US$544.75380.0006% mcap0.0% of flowCommon StockSEC:0001106578-26-000165:5
825 shares@ US$545.87470.0019% mcap0.1% of flowCommon StockSEC:0001106578-26-000165:6
601 shares@ US$546.94280.0014% mcap0.0% of flowCommon StockSEC:0001106578-26-000165:7
1,009 shares@ US$549.7560.0024% mcap0.1% of flowCommon StockSEC:0001106578-26-000165:10
200 shares@ US$550.7160.0005% mcap0.0% of flowCommon StockSEC:0001106578-26-000165:11
120 shares@ US$551.500.0003% mcap0.0% of flowCommon StockSEC:0001106578-26-000165:12
2,166 shares@ US$547.82680.0051% mcap0.2% of flowCommon StockSEC:0001106578-26-000165:8
2,039 shares@ US$548.88820.0048% mcap0.1% of flowCommon StockSEC:0001106578-26-000165:9
281 shares@ US$540.47640.0007% mcap0.0% of flowCommon StockSEC:0001106578-26-000165:1
9,500 shares@ US$117.760.0048% mcap0.2% of flowCommon StockSEC:0001106578-26-000164:0
40 shares@ US$526.070.0001% mcap0.0% of flowCommon StockSEC:0001106578-26-000164:1
160 shares@ US$530.08750.0004% mcap0.0% of flowCommon StockSEC:0001106578-26-000164:2
120 shares@ US$531.18670.0003% mcap0.0% of flowCommon StockSEC:0001106578-26-000164:3
40 shares@ US$532.480.0001% mcap0.0% of flowCommon StockSEC:0001106578-26-000164:4
240 shares@ US$534.63330.0006% mcap0.0% of flowCommon StockSEC:0001106578-26-000164:5
400 shares@ US$535.89030.0009% mcap0.0% of flowCommon StockSEC:0001106578-26-000164:6
633 shares@ US$537.18580.0015% mcap0.0% of flowCommon StockSEC:0001106578-26-000164:7
1,127 shares@ US$538.00030.0026% mcap0.1% of flowCommon StockSEC:0001106578-26-000164:8
525 shares@ US$539.09170.0012% mcap0.0% of flowCommon StockSEC:0001106578-26-000164:9
2,002 shares@ US$540.23190.0047% mcap0.1% of flowCommon StockSEC:0001106578-26-000164:10
1,930 shares@ US$541.19640.0045% mcap0.1% of flowCommon StockSEC:0001106578-26-000164:11
25 of 1450 declarations
